| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0db8f8ba5107d9d953fa5c616fdfc65e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4471cb5e5f3841893dcd446776544111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c50a38897767b90b3f9e84925e7f9b69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ab51c51ed9e534ac00732cb36cb1780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9d696f6574d320ecb6faf3cb6014cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c90caf1d4ab73f6a3bfebe323f31f3b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 |
| filingDate |
2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905904fc1c3b93b2325174e1a2fea556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b683e19cd8a31f589ba0e41f9eae81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e0063486e59feb1ca6629b4303ac6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b9a29ff946167643258686bc8b12d1 |
| publicationDate |
2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009106642-A1 |
| titleOfInvention |
Biosynthetic cartilaginous matrix and methods for their production |
| abstract |
An isolated, acellular biosynthetic cartilaginous matrix substantially devoid of synthetic biodegradable scaffold structure is provided. Through a method with the steps of a) contacting in vitro a population of chondrogenic cells with a synthetic biodegradable scaffold; b) culturing in vitro for a period of time said chondrogenic cells within said synthetic biodegradable scaffold so that the chondrogenic cells produce a biosynthetic cartilaginous matrix; c) substantially removing any antigen derived from said chondrogenic cells a matrix suitable of implantation into a living individual mammal, such as a human being is obtained. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110397470-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102416201-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110448714-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2543397-A4 |
| priorityDate |
2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |